Matinas BioPharma Hldgs Historical PE Ratio image   This MTNB PE ratio history page last updated 4/29/2024
Matinas BioPharma Hldgs Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/27/2024
0.29-0.03-0.12NA
Q3 2023
11/8/2023
0.28-0.03-0.12NA
Q2 2023
8/9/2023
0.33-0.03-0.12NA
Q1 2023
5/10/2023
0.67-0.03-0.12NA
Q4 2022
3/15/2023
0.43-0.02-0.08NA
Q3 2022
11/2/2022
0.79-0.03-0.12NA
Q2 2022
8/11/2022
0.85-0.03-0.12NA
Q1 2022
5/12/2022
0.64-0.03-0.12NA
Q4 2021
3/8/2022
0.58-0.03-0.12NA
Q3 2021
11/8/2021
1.01-0.03-0.12NA
Q2 2021
8/10/2021
0.73-0.02-0.08NA
Q1 2021
5/10/2021
0.77-0.03-0.12NA
Q4 2020
3/29/2021
1.06-0.03-0.12NA
Q3 2020
11/6/2020
0.85-0.03-0.12NA
Q2 2020
8/10/2020
0.92-0.03-0.12NA
Q1 2020
5/11/2020
0.76-0.03-0.12NA
Q4 2019
3/9/2020
0.94-0.04-0.16NA
Q3 2019
11/13/2019
0.90-0.03-0.12NA
Q2 2019
8/13/2019
0.71-0.03-0.12NA
Q1 2019
5/14/2019
0.95-0.04-0.16NA
Q4 2018
4/2/2019
1.06-0.03-0.12NA
Q3 2018
11/12/2018
0.96-0.03-0.12NA
Q2 2018
8/10/2018
0.37-0.04-0.16NA
Q1 2018
5/10/2018
0.53-0.05-0.20NA
Q4 2017
3/19/2018
1.04-0.03-0.12NA
Q3 2017
11/15/2017
1.10-0.04-0.16NA
Matinas BioPharma Hldgs PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/27/2024
0.29-0.03-0.12NA
Q3 2023
11/8/2023
0.28-0.03-0.11NA
Q2 2023
8/9/2023
0.33-0.03-0.11NA
Q1 2023
5/10/2023
0.67-0.03-0.11NA
Q4 2022
3/15/2023
0.43-0.02-0.11NA
Q3 2022
11/2/2022
0.79-0.03-0.09NA
Q2 2022
8/11/2022
0.85-0.03-0.09NA
Q1 2022
5/12/2022
0.64-0.03-0.09NA
Q4 2021
3/8/2022
0.58-0.03-0.11NA
Q3 2021
11/8/2021
1.01-0.03-0.11NA
Q2 2021
8/10/2021
0.73-0.02-0.11NA
Q1 2021
5/10/2021
0.77-0.03-0.12NA
Q4 2020
3/29/2021
1.06-0.03-0.12NA
Q3 2020
11/6/2020
0.85-0.03-0.13NA
Q2 2020
8/10/2020
0.92-0.03-0.13NA
Q1 2020
5/11/2020
0.76-0.03-0.13NA
Q4 2019
3/9/2020
0.94-0.04-0.14NA
Q3 2019
11/13/2019
0.90-0.03-0.13NA
Q2 2019
8/13/2019
0.71-0.03-0.13NA
Q1 2019
5/14/2019
0.95-0.04-0.14NA
Q4 2018
4/2/2019
1.06-0.03-0.15NA
Q3 2018
11/12/2018
0.96-0.03-0.15NA
Q2 2018
8/10/2018
0.37-0.04-0.16NA
Q1 2018
5/10/2018
0.53-0.05NANA
Q4 2017
3/19/2018
1.04-0.03NANA
Q3 2017
11/15/2017
1.10-0.04NANA
How should the MTNB historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Matinas BioPharma Hldgs. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this MTNB Historical PE Ratio page.

What is the average historical PE for MTNB based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The MTNB historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for MTNB based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The MTNB historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Matinas BioPharma Hldgs Historical PE Ratio information for Matinas BioPharma Hldgs' stock. The average MTNB historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MTNB historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this MTNB historical PE result, against the recent PE: when this page was posted on 4/26/2024, the most recent closing price for MTNB had been 0.18, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on MTNB or any other given stock, valuation analysis for MTNB can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Matinas BioPharma Hldgs PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MTNB. Thanks for visiting, and the next time you need to research MTNB Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: OLP YTD Return, LRFC YTD Return, VGEM Options Chain.

 

Matinas BioPharma Hldgs Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.